Updated Jul 16, 2026
Norwalk Leslie V has filed 6 SEC Form 4 filings across 3 companies in the last 90 days — selling. Lifetime open-market sales: $1.36M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-26 | ARVN | ARVINAS, INC. | A — Grant or award | 15.5K | $0.00 | |
| 2026-06-08 | NBIX | NEUROCRINE BIOSCIENCES INC | S — Open-market sale | 1.2K | $168.06 | $210K |
| 2026-05-21 | NBIX | NEUROCRINE BIOSCIENCES INC | M — Option exercise | 1.7K | $0.00 | |
| 2026-05-15 | CVS | CVS HEALTH Corp | A — Grant or award | 1.4K | $97.15 | $141K |
| 2026-05-14 | NBIX | NEUROCRINE BIOSCIENCES INC | S — Open-market sale | 3.8K | $155.01 | $591K |
| 2026-01-12 | GMED | GLOBUS MEDICAL INC | S — Open-market sale [10b5-1] | 2.0K | $101.10 | $202K |
| 2025-12-16 | GMED | GLOBUS MEDICAL INC | S — Open-market sale [10b5-1] | 4.0K | $88.85 | $355K |
| 2024-11-25 | CVS | CVS HEALTH Corp | A — Grant or award | 2.2K | $57.10 | $126K |
Norwalk Leslie V is a corporate insider — currently tracked as Director of ARVINAS, INC. (ARVN). InsiderAlpha tracks every SEC Form 4 filing in real time.
6 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($1.36M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Norwalk Leslie V profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.